The clinical and economic significance of atherosclerosis

American Journal of Medicine

Volumn 101, Issue 4 A, 1996, Pages 6S-9S

  Stone, Neil J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ATHEROSCLEROSIS; BLOOD PRESSURE; CAUSE OF DEATH; CIGARETTE SMOKING; CONFERENCE PAPER; DRUG COST; ECONOMIC ASPECT; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MALE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RISK FACTOR; RISK MANAGEMENT; UNITED STATES;

EID: 85007114758     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(96)00315-4     Document Type: Conference Paper

References (15)

1. Singh GK, Mathews TJ, Clarke SC, et al. Annual summary of births, marriages, divorces, and deaths: United States, 1994. Monthly vital statistics report; vol 43 no 13. Hyattsville, MD: National Center for Health Statistics. 1995.
2. Heart and Stroke Facts: 1996 Statistical Supplement, American Heart Association. 1995.
3. Graves EJ. 1993 Summary: national hospital discharge survey. Advance data from vital and health statistics; no 264. Hyattsville, MD: National Center for Health Statistics. 1995.
4. Meyers DG. Relative survival benefits of risk factor modifications. Am J Cardiol. 1996;77:298-299.
5. Oster G. Estimated effects of reducing dietary saturated fat intake on the incidence and costs of coronary heart disease in the United States. J Am Diet Assoc. 1996;96:127-131.
6. Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med. 1995;333:1301-1307.
7. Superko HR, Krauss RM. Coronary artery disease regression. Convincing evidence for the benefit of aggressive lipoprotein management. Circulation. 1994;90:1056-1069.
8. Brown G, Albers JJ, Fisher LD, Schaefer SM, Lin JT, Kaplan CK, Zhao XQ, Bisson BD, Fitzpatrick VF, Dodge HT. Regression of coronary artery disease as a result of interim lipid-lowering therapy in men with high levels of apolipoprotein B. N Engl J Med. 1990;323:1289-1298.
9. Buchwald H, Varco RL, Matts JP, et al. Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. N Engl J Med. 1990;323:946-955.
10. Blankenhorn DH, Nessim SA, Johnson RL, Samarco ME, Azen SP, Cashin-Hemphill L. Beneficial effects of colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. JAMA. 1987;257:3233-3240.
11. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344:1383-1389.
12. Pedersen TR, Kjekshus J, Berg K, Olsson AG, Wilhelmsen L, Wedel H, et al. Cholesterol lowering and the use of healthcare resources. Results of the Scandinavian Simvastatin Survival Study. Circulation. 1996;93:1796-1802.
13. Pfeffer MA, Sacks FM, Move LA, Brown L, Rouleau JL, Hartley BH, Rouleau J, Grimm R, Sestier F, Wickemeyer W, Cole TG, Braunwald E. Cholesterol and Recurrent Events: a secondary prevention trial for normolipidemic patients. Am J Cardiol. 1995;76:98C-106C.
14. Campeau L, Hunninghake DB, Domanski MJ. Post-CABG Trial: design and results. Reported at the American College of Cardiology, 45th Annual Session, Orlando, FL, March 24-26, 1996.
15. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Summary of the Second Report of the National Cholesterol Education (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA. 1993;269:3015-3023.